Completed
MASCOT : Multicenter Asia Study in Adjuvant Treatment of Colon Cancer With OxaliplaTin/5FU-LV
NCT00263055
- Conditions
- Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +8 more
- Locations
-
- Sanofi-Aventis Beijing, China
- Sanofi-Aventis Hong Kong
- Sanofi-aventis Seoul, South Korea
- Sanofi-Aventis Taipei, Taiwan